Weight adjusted partial correlation analysis of BMD levels with clinical and biochemical findings of the patients
| L2-L4 T | L2-L4 Z | FN-T | FN-Z | FT-T | FT- Z | |
|---|---|---|---|---|---|---|
| eGFR (mL/min/1.73 m2) | r: 0.027 p:0.808 | r:0.070 p:0.534 | r:−0.037 p:0.743 | r:0.047 p:0.675 | r:0.060 p:0.593 | r:0.155 p:0.163 |
| CaXPO4 | r: 0.056 p:0.615 | r:0.016 p:0.889 | r:0.043 p:0.698 | r:0.046 p:0.683 | r:0.100 p:0.371 | r:0.071 p:0.529 |
| 25hD (µg/L) | r:0.046 p:0.682 | r: −0.007 p:0.950 | r:0.035 p:0.758 | r:0.039 p:0.729 | r:0.040 p:0.723 | r: −0.089 p:0.429 |
| Serum AP (U/L) | r: −0.159 p:0.214 | r: −0.105 p:0.413 | r: −0.326 p:0.009 | r: −0.272 p:0.031 | r: −0.314 p:0.012 | r: −0.337 p:0.007 |
| BSAP (U/L) | r: −0.174 p:0.125 | r: −0.121 p:0.287 | r: −0.344 p:0.002 | r: −0.366 p:0.001 | r: −0.304 p:0.006 | r: −0.347 p:0.002 |
| HCO3 | r:0.148 p:0.241 | r:0.132 p:0.296 | r:0.270 p:0.029 | r:0.302 p:0.015 | r:0.215 p:0.085 | r:0.243 p:0.051 |
Bold denotes p<0.05 is significant.
25hD, 25-hydroxy-vitamin D; BSAP, bone-specific Alkaline phosphatase; eGFR, estimated glomerular filtration rate; FN, femoral neck; FT, femoral trochanter; Serum AP, serum-specific alkaline phosphatases.